HHSC to Resume Quarterly Specialty Drug List in July 2021

Published on
May 13, 2021

Texas Administrative Code Title 1, Section 354.1853 requires HHSC to routinely update the list of specialty drugs included on the Specialty Drug List (SDL). HHSC suspended updates to the SDL due to concerns of potential drug shortages during the COVID-19 public health emergency. The 2019 quarter 4 SDL is still in effect.

Drug shortages experienced at the beginning of the COVID-19 public health emergency have resolved and not recurred. HHSC will continue to monitor for any drug shortages as we resume publication of the SDL. HHSC expects to publish the draft SDL on the VDP website in late May. HHSC will send further instruction as part of the usual SDL solicitation process.